Ocular Surface Review

Call the Exterminator

A new eye drop, Xdemvy, shows positive results in wiping out the unusually common condition known as Demodex blepharitis.
09/15/2023

First of its Kind

Miebo now gives us a medication option that targets MGD and evaporative DED.
07/15/2023

Drink Up

Hydrating the whole body—not just the eyes—is key to improving the ocular surface.
05/15/2023

Toxic Work Environment

Be aware of certain glaucoma therapy options that could harm the ocular surface.
03/15/2023

Right Tool for the Job

These small but mighty instruments can help you better perform a number of procedures and will enhance your practice.
02/15/2023

Making the Grade

Studies show promising results for CyclASol, a new medication to treat DED that could be approved next year.
11/15/2022

Revisit a Steroid Alternative

Acthar Gel, an injectable therapy that activates melanocortin pathways, may be a saving grace for some of your patients.
09/15/2022

Power Trio

Three promising new therapeutics look to dramatically change dry eye disease management.
07/15/2022

Night Moves

Inadequate lid closure, caused by nocturnal evaporative stress, may be the reason for your patient’s dry eye.
06/15/2022

A Sticky Subject

Mucin dysfunction in dry eye is more common than you think.
03/15/2022

Upcoming Events

October 3, 2023

Addressing a Major Gap in the Treatment of Dry Eye Disease
Location: Virtual
Presenters: Damon Dierker, OD, and Jennifer Loh, MD
Webinar: 8:00pm ET

Sponsored by Bausch + Lomb

Register here

October 5, 2023

Addressing a Major Gap in the Treatment of Dry Eye Disease
Location: Virtual
Presenters: Mile Brujic, OD, and Sheri Rowen, MD
Webinar: 7:00pm ET

Sponsored by Bausch + Lomb

Register here

October 11, 2023

Showcasing Inflammation and IOP Control
Location: Dickie Brennan's Palace Café
Presenters: Nora Cothran, OD, and Michael Chaglasian, OD
Presentation: 7:00pm CT

Sponsored by Bausch + Lomb

Register here